Literature DB >> 192572

Potentiation by crude kallikrein of the myotropic effect of angiotensin I in the isolated rabbit aortic strip.

Z S Ercan, R K Türker.   

Abstract

Crude kallikrein (Padutin), but not pure kallikrein, when preincubated with angiotensin I caused a potentiation of the myotropic effect of decapeptide on the isolated continuously superfused rabbit aortic strip. Addition of converting enzyme inhibitor, SQ 20881, to the medium inhibited this potentiation. The potentiation by crude kallikrein of the myotropic effect of angiotensin I is probably due to the conversion of decapeptide to octapeptide angiotensin II. This study indicates that Padutin is not a pure kallikrein preparation and probably contains a kininase fraction which causes the conversion of angiotensin I.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192572     DOI: 10.1007/bf02002832

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  5 in total

1.  Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs.

Authors:  R F FURCHGOTT; S BHADRAKOM
Journal:  J Pharmacol Exp Ther       Date:  1953-06       Impact factor: 4.030

2.  Change of activity in rabbit aorta of three analogs of angiotensin substituted in nh2-terminal position.

Authors:  R K Türker; Z S Ercan
Journal:  Pharmacology       Date:  1975       Impact factor: 2.547

3.  Effects of the nonapeptide SQ 20881 on blood pressure of rats with experimental renovascular hypertension.

Authors:  S L Engel; T R Schaeffer; M H Waugh; B Rubin
Journal:  Proc Soc Exp Biol Med       Date:  1973-06

4.  High degree of conversion of angiotensin I to angiotensin II in the mesenteric circulation of the isolated perfused terminal ileum of the cat.

Authors:  R K Türker; Z S Ercan
Journal:  Arch Int Physiol Biochim       Date:  1975-12

5.  Conversion of angiotensin I to angiotensin II.

Authors:  K K Ng; J R Vane
Journal:  Nature       Date:  1967-11-25       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.